Nathan Taylor

Nate has represented:

• Cantor Fitzgerald
• UBS Financial Services
• Credit Suisse
• Harley-Davidson
• New Enterprise Associates
• PIMCO
• Tata Consultancy Services
• Dex Media
• Teva Pharmaceuticals*
• Upsher-Smith Pharmaceuticals*

*Client represented prior to joining Latham

Nate’s experience includes representing:

• Cantor Fitzgerald and Howard Lutnick in securing a complete defense verdict after trial under the “entire fairness” standard in Delaware Chancery Court and on appeal before the Delaware Supreme Court in a case brought by shareholders of BGC Partners, related to BGC’s acquisition of Berkeley Point from Cantor for US$875 million
• Larry Ellison (Executive Chairman and Chief Technology Officer, Oracle Corporation) and Safra Catz (CEO, Oracle Corporation) in securing a complete victory for the defendants in derivative litigation before the Delaware Court of Chancery in a challenge to Oracle’s US$9.3 billion acquisition of NetSuite, after a finding that Mr. Ellison was not a controller of Oracle
• A global Swiss bank alleged to have misappropriated software in an arbitration in which the claimant sought over US$1.7 billion, resulting in a complete verdict in favor of the client after a seven-day arbitration hearing and dismissal of all claims
• A global Swiss bank in a whistleblower retaliation lawsuit brought by a former executive, resulting in a complete defense verdict after an 11-day trial
• A national SaaS small business provider and directories publisher charged with copyright infringement in an action seeking US$750 million in damages, as well as a series of follow-on lawsuits, in which the publisher prevailed at trial before the Bankruptcy Court for the District of Delaware and obtained an award of client’s attorneys’ fees exceeding US$700,000
• A global private equity investment firm in litigation related to ownership over a national trucking and shipping company, resulting in a final award in the client’s favor following a six-day arbitration hearing
• A leading venture capital firm in successful plaintiff-side litigation in Delaware Chancery Court alleging breach of fiduciary duty, tortious interference, and disclosure violations in connection with an investment in a cybersecurity company
• A generic pharmaceutical manufacturer in antitrust litigation arising out of patent litigation settlements*
• A generic pharmaceutical manufacturer in antitrust litigation claiming alleged price-fixing of generic pharmaceuticals*

*Matter handled prior to joining Latham